FDA Inspection 1265673 — Kulkanya Chokephaibulkit
The FDA completed an inspection of Kulkanya Chokephaibulkit on Mar 13, 2025 in Bangkok. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 13, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bangkok (Thailand)
Additional details
Clinical Investigator (CI)